Ballicules.com

Fluphenazine

PROLIXIN

What it isHigh-potency first-generation antipsychotic; schizophrenia.

Why this oneIts depot is usually given more often than haloperidol decanoate, allowing quicker adjustment but requiring more injection visits.

What limits itHigh extrapyramidal and tardive dyskinesia risk. Little anticholinergic or metabolic burden by comparison.

FDA-approved for

FDA label

BOXED WARNING Increased mortality in elderly patients with dementia-related psychosis treated with antipsychotics; not approved for dementia-related psychosis.
FDA dosingPopulationStartTargetMax
Psychotic disordersAdult2.5-10 mg/day divided q6-8h<20 mg/day40 mg/day
Psychotic disorders (maintenance)Adult1-5 mg/day, often single daily dose1-5 mg/day40 mg/day
Psychotic disordersGeriatric1-2.5 mg/dayper responseper response

Renal Undefined

Hepatic Contraindicated with liver damage

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Undefined

Lactation Undefined

⚠ BOXED WARNING

Cost, est. cash$20–$1,500/dose or month

Generic entry1987

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability1 / 4
Sedation liability1 / 4
QT / Torsades1 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilityMetabolic effects, extrapyramidal symptoms/tardive dyskinesia and agent-specific QT or orthostatic risk.

Mechanism of action: Fluphenazine ballicule

Fluphenazine ballicule: receptor binding, kinetics and half-life diagram

Open Fluphenazine in the interactive console ↗

Memory aids: mascots and interaction avatars

Fluphenazine PROLIXIN mascot mnemonic cartoon
“Prolix Fluffy hen”
Spooky greyscale mascot → high-potency first generation antipsychotic (FGA)
Prolix (adjective) - speaking at great length, wordy, redundant
Fluphenazine CYP2D6 substrate avatar
CYP2D6 substrate

Open Fluphenazine in the interactive console ↗